Skip to search formSkip to main contentSkip to account menu

NELFB gene

Known as: KIAA1182, negative elongation factor complex member B, COFACTOR OF BRCA1 
This gene is involved in pausing transcriptional elongation.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Germ-line mutations in breast cancer susceptibility gene, BRCA1, result in familial predisposition to breast and ovarian cancers… 
2018
2018
COBRA1 (co-factor of BRCA1) is one of the four subunits of the negative elongation factor originally identified as a BRCA1… 
2016
2016
The breast cancer susceptibility gene BRCA1 is well known for its function in double-strand break (DSB) DNA repair. While BRCA1… 
Review
2015
Review
2015
.......................................................................................................................................... v List of Abbreviations ................................................................................................................... viii List of Tables ................................................................................................................................. xi List of Figures ............................................................................................................................... xii Chapter (1): Literature review .................................................................................................... 1 1.1 Hepatocellular Carcinoma (HCC) ......................................................................................... 1 1.1.1 HCC Epidemiology: Incidence and Prevalence ........................................................ 1 1.1.2 Risk Factors and Prevention ..................................................................................... 1 1.1.3 Diagnosis................................................................................................................... 2 1.1.4 Staging Systems in HCC ........................................................................................... 3 1.1.5 HCC Treatment ......................................................................................................... 4 1.1.6 HCC Molecular Pathogenesis ................................................................................... 5 1.2 Cofactor of BRCA1 (COBRA1) ........................................................................................... 6 1.2.1 Negative Elongation Factor (NELF) Complex ......................................................... 7 1.2.2 Activator Protein-1 (AP-1) complex ......................................................................... 9 1.2.3 Trefoil Factor 1 (TFF1) ........................................................................................... 10 1.3 Cell Culture ......................................................................................................................... 11 Study Objectives and Experimental Design .............................................................................. 12 Chapter (2): Materials and Methods ......................................................................................... 14 2.1 Cell culture .......................................................................................................................... 14 2.2 RNA extraction, quantification and cDNA synthesis ......................................................... 16 2.3 RT-PCR ............................................................................................................................... 16 2.4 Protein extraction and quantification .................................................................................. 17 2.5 Western blotting .................................................................................................................. 17 2.6 Statistical analysis ............................................................................................................... 18 Chapter (3): Results .................................................................................................................... 20 3.1 The morphology of studied cell lines .................................................................................. 20 3.2 Molecular analysis results ................................................................................................... 21 
2015
2015
Cofactor of BRCA1 (COBRA1) is one of the four subunits that make up the Negative Elongation Factor Complex (NELF) which is… 
Highly Cited
2008
Highly Cited
2008
Cofactor of BRCA1 (COBRA1) is an integral component of the human negative elongation factor (NELF), a four‐subunit protein… 
2007
2007
Cofactor of BRCA1 (COBRA1) was first identified as a protein that binds to the breast cancer susceptibility gene product BRCA1… 
2006
2006
Cofactor of BRCA1 (COBRA1) is a newly characterized member of the negative elongation factor (NELF) complex. In this work, we…